Status:
COMPLETED
Cleansing Efficacy of Cosmetic Product
Lead Sponsor:
Amazentis SA
Collaborating Sponsors:
SGS proderm GmbH
Conditions:
Healthy Skin
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the cleansing effect of one cosmetic product containing Mitopure against a particular matter model pollutant in comparison to an untreated control.
Eligibility Criteria
Inclusion
- Written informed consent to participate in the study
- Willingness to actively participate in the study and to come to the scheduled visits
- Female and/or male
- From 18 to 70 years of age
- Healthy skin in the test area
- Skin type on Fitzpatrick scale: I, II or III
Exclusion
- Female subjects: Pregnancy or lactation
- Drug addicts, alcoholics
- AIDS, HIV-positive or infectious hepatitis
- Conditions which exclude a participation or might influence the test reaction/evaluation
- Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
- Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
- Active skin disease at the test area
- Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
- Any topical medication at the test area within the last 4 weeks prior to the start of the study and during the study
- Documented allergies to cosmetic products and/or ingredients
Key Trial Info
Start Date :
May 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06956625
Start Date
May 8 2025
End Date
May 9 2025
Last Update
June 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SGS proderm GmbH
Schenefeld, Germany